The landscape of dementia prognosis has developed significantly with the arrival of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of indicators arise. While these technological improvements characterize remarkable progress in comprehension neurod